Bonesupport Holding AB

Equities

BONEX

SE0009858152

Pharmaceuticals

Market Closed - Nasdaq Stockholm 12:00:01 2024-07-17 pm EDT 5-day change 1st Jan Change
275.2 SEK +0.22% Intraday chart for Bonesupport Holding AB -3.44% +46.23%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Bonesupport Raises Sales Guidance for the Year 2024 CI
Transcript : Bonesupport Holding AB, Q2 2024 Earnings Call, Jul 11, 2024
Bonesupport Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
Bonesupport AB Announces Market Submission for Cerament V in the US to Be a 510(K) CI
Bonesupport Holding AB Appoints Anna Stegmark as EVP Quality Management & Regulatory Affairs, with Effect from 1 July 2024 CI
Cerament® Contributes to Fewer Amputations - New Data from Australia CI
Transcript : Bonesupport Holding AB, Q1 2024 Earnings Call, Apr 25, 2024
Bonesupport Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Nordic Shares Decreased Friday; BoneSupport Holding Posted Biggest Loss DJ
Nordic Stocks Moved Upward Thursday; Scatec Climbed Highest DJ
Bonesupport’s Orthopedic Medical Device for Open Fractures Gains US FDA Nod MT
Nordic Shares Moved Upward Wednesday; BoneSupport Holding Topped Leaders DJ
Bonesupport Holding AB Announces Resignation of Kristina Ingvar as Executive Vice President Quality Management & Regulatory Affairs CI
Nordic Stocks Closed Up Monday; Tele2 Series a Topped Leaders DJ
Nordic Stocks Closed Up Friday; Yubico Led Increases DJ
Bonesupport Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Bonesupport Holding AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Transcript : Bonesupport Holding AB, 2023 Earnings Call, Feb 15, 2024
Transcript : Bonesupport Holding AB - Analyst/Investor Day
Bonesupport Holding AB Provides Sales Guidance for the Year 2024 CI
Bonesupport Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Bonesupport Holding AB, Nine Months 2023 Earnings Call, Oct 26, 2023
Bone Support Receives ?Breakthrough Device Designation? for Cerament® V for the Indication of Bone Infection CI
Transcript : Bonesupport Holding AB, Q2 2023 Earnings Call, Jul 13, 2023
Bonesupport Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Chart Bonesupport Holding AB
More charts
Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
275.2 SEK
Average target price
310 SEK
Spread / Average Target
+12.65%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. BONEX Stock
  4. News Bonesupport Holding AB
  5. Bonesupport’s Orthopedic Medical Device for Open Fractures Gains US FDA Nod